Medtronic Minimed, Inc.
Clinical trials sponsored by Medtronic Minimed, Inc., explained in plain language.
-
Smart insulin pump shows promise for type 2 diabetes control
Disease control CompletedThis study tested whether the MiniMed 780G automated insulin pump is safe and effective for adults with type 2 diabetes who need insulin. Over 500 participants used the system at home for about 4.5 months. The goal was to see if the pump improved blood sugar control without causi…
Phase: NA • Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Apr 26, 2026 17:06 UTC
-
Smart pen vs. standard shots: which controls diabetes better?
Disease control CompletedThis study tested a new 'Smart MDI' system, which combines a smart insulin pen with a glucose sensor, against standard insulin injections for people with type 1 diabetes. Over 6 months, researchers compared how well each method kept blood sugar in a healthy range. The goal was to…
Phase: NA • Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Apr 21, 2026 12:43 UTC
-
Tiny testers: new insulin pump safety checked in kids as young as 2
Disease control CompletedThis study tested the safety of a new automated insulin pump and glucose monitor system for very young children with type 1 diabetes. It involved 56 children aged 2 to 6 years who used the device system at home for about four months. The main goal was to see how safe the system w…
Phase: NA • Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Apr 20, 2026 16:17 UTC